{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:07:06Z","timestamp":1793387226888,"version":"4.5.0"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A2B5B01001646"],"award-info":[{"award-number":["NRF-2020R1A2B5B01001646"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017M3A9B6061512"],"award-info":[{"award-number":["NRF-2017M3A9B6061512"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2016M3A9D5A01952416"],"award-info":[{"award-number":["NRF-2016M3A9D5A01952416"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Intrahepatic cholangiocarcinoma (iCCA) is an aggressive primary liver malignancy with an increasing incidence worldwide. Recently, histopathologic classification of small duct type and large duct type iCCA has been introduced. Both these types of tumors exhibit differences in clinicopathological features, mutational profiles, and prognosis. Small duct type iCCA is composed of non-mucin-producing cuboidal cells, whereas large duct type iCCA is composed of mucin-producing columnar cells, reflecting different cells of origin. Large duct type iCCA shows more invasive growth and poorer prognosis than small duct type iCCA. The background liver of small duct type iCCA often shows chronic liver disease related to hepatitis B or C viral infection, or alcoholic or non-alcoholic fatty liver disease\/steatohepatitis, in contrast to large duct type iCCA that is often related to hepatolithiasis and liver fluke infection. Cholangiolocarcinoma is a variant of small duct type iCCA composed of na\u00efve-looking cuboidal cells forming cords or ductule-like structures, and shows better prognosis than the conventional small duct type. Fibrous tumor stroma, one of the characteristic features of iCCA, contains activated fibroblasts intermixed with innate and adaptive immune cells. The types of stroma (mature versus immature) are related to tumor behavior and prognosis. Low tumor-infiltrating lymphocyte density,\n                    <jats:italic>KRAS<\/jats:italic>\n                    alteration, and chromosomal instability are related to immune-suppressive tumor microenvironments with resistance to programmed death 1\/ programmed death ligand 1 blockade. Data from recent large-scale exome analyses have revealed the heterogeneity in the molecular profiles of iCCA, showing that small duct type iCCA exhibit frequent\n                    <jats:italic>BAP1<\/jats:italic>\n                    ,\n                    <jats:italic>IDH1\/2<\/jats:italic>\n                    hotspot mutations and\n                    <jats:italic>FGFR2<\/jats:italic>\n                    fusion, in contrast to frequent mutations in\n                    <jats:italic>KRAS<\/jats:italic>\n                    ,\n                    <jats:italic>TP53<\/jats:italic>\n                    , and\n                    <jats:italic>SMAD4<\/jats:italic>\n                    observed in large duct type iCCA. Multi-omics analyses have proposed several molecular classifications of iCCA, including inflammation class and proliferation class. The inflammation class is enriched in inflammatory signaling pathways and expression of cytokines, while the proliferation class has activated oncogenic growth signaling pathways. Diverse pathologic features of iCCA and its associated multi-omics characteristics are currently under active investigation, thereby providing insights into precision therapeutics for patients with iCCA. This review provides the latest knowledge on the histopathologic classification of iCCA and its associated molecular features, ranging from tumor microenvironment to genomic and transcriptomic research.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2022.857140","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T02:56:22Z","timestamp":1648695382000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":70,"title":["Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma"],"prefix":"10.3389","volume":"9","author":[{"given":"Taek","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Nyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-40618-3_25","article-title":"Perihilar bile ducts.","author":"Nagorney","year":"2017","journal-title":"AJCC Cancer Staging Manual."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1073274817729245","DOI":"10.1177\/1073274817729245","article-title":"Epidemiology of Hepatocellular carcinoma and intrahepatic cholangiocarcinoma.","volume":"24","author":"Massarweh","year":"2017","journal-title":"Cancer Control."},{"key":"B3","article-title":"Intrahepatic cholangiocarcinoma.","author":"Nakanuma","year":"2019","journal-title":"Digestive System Tumours."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/cncr.32803","article-title":"Global incidence of and trends in intrahepatic and extrahepatic cholangiocarcinoma from 1993 to 2012.","volume":"126","author":"Florio","year":"2020","journal-title":"Cancer."},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors.","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3347\/kjp.2016.54.2.215","article-title":"Prevalence of Clonorchis sinensis Infection among residents along 5 major rivers in the republic of Korea.","volume":"54","author":"Jeong","year":"2016","journal-title":"Korean J Parasitol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.52939\/ijg.v17i2.1759","article-title":"National program of opisthorchiasis in Thailand; situation and policy strategy.","volume":"17","author":"Kitphati","year":"2021","journal-title":"Int J Geoinf."},{"key":"B8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management.","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2147\/ott.S93629","article-title":"Intrahepatic cholangiocarcinoma: current perspectives.","volume":"10","author":"Buettner","year":"2017","journal-title":"OncoTargets Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1038\/s41598-021-83149-5","article-title":"Clinicopathological characteristics and prognostic factors for intrahepatic cholangiocarcinoma: a population-based study.","volume":"11","author":"Yu","year":"2021","journal-title":"Sci Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1002\/hep.32007","article-title":"Comparison of clinical features and outcomes between intrahepatic cholangiocarcinoma and hepatocellular carcinoma in the United States.","volume":"74","author":"Lee","year":"2021","journal-title":"Hepatology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/pas.0000000000000670","article-title":"Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma.","volume":"40","author":"Hayashi","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles.","volume":"18","author":"Farshidfar","year":"2017","journal-title":"Cell Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.","volume":"2","author":"Cerami","year":"2012","journal-title":"J Cancer Discov."},{"key":"B15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00534-002-0732-8","article-title":"Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.","volume":"10","author":"Yamasaki","year":"2003","journal-title":"J Hepatobiliary Pancreat Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1586\/17474124.2016.1104246","article-title":"Latest advances in the pathological understanding of cholangiocarcinomas.","volume":"10","author":"Nakanuma","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.hpb.2019.10.009","article-title":"Clinicopathological characteristics of intrahepatic cholangiocarcinoma according to gross morphologic type: cholangiolocellular differentiation traits and inflammation- and proliferation-phenotypes.","volume":"22","author":"Chung","year":"2020","journal-title":"HPB."},{"key":"B18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00428-018-02511-7","article-title":"DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.","volume":"475","author":"Kim","year":"2019","journal-title":"Virchows Arch."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1097\/pas.0000000000001118","article-title":"Intrahepatic cholangiocarcinomas have histologically and immunophenotypically distinct small and large duct patterns.","volume":"42","author":"Sigel","year":"2018","journal-title":"Am J Surg Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jhbp.154","article-title":"Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.","volume":"22","author":"Aishima","year":"2015","journal-title":"J Hepatobiliary Pancreat Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.hpb.2018.07.021","article-title":"Histological and molecular characterization of intrahepatic bile duct cancers suggests an expanded definition of perihilar cholangiocarcinoma.","volume":"21","author":"Akita","year":"2019","journal-title":"HPB (Oxford)."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/hep.25595","article-title":"Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes.","volume":"55","author":"Komuta","year":"2012","journal-title":"Hepatology."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/hep.510300614","article-title":"The canals of Hering and hepatic stem cells in humans.","volume":"30","author":"Theise","year":"1999","journal-title":"Hepatology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1158\/0008-5472.CAN-13-1911","article-title":"Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma.","volume":"74","author":"Guest","year":"2014","journal-title":"J Cancer Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"100226","DOI":"10.1016\/j.jhepr.2021.100226","article-title":"Cell of origin in biliary tract cancers and clinical implications.","volume":"3","author":"Moeini","year":"2021","journal-title":"JHEP Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/j.1365-2559.2012.04316.x","article-title":"S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.","volume":"61","author":"Tsai","year":"2012","journal-title":"Histopathology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2559.2006.02414.x","article-title":"Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.","volume":"49","author":"Aishima","year":"2006","journal-title":"Histopathology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/modpathol.2011.41","article-title":"Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression.","volume":"24","author":"Yu","year":"2011","journal-title":"Mod Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1365-2559.2007.02735.x","article-title":"A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: \u2018bile ductular carcinoma\u2019.","volume":"51","author":"Kozaka","year":"2007","journal-title":"Histopathology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.humpath.2020.12.005","article-title":"An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.","volume":"109","author":"Akita","year":"2021","journal-title":"Hum Pathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.21037\/hbsn.2016.11.04","article-title":"Pathology of intrahepatic cholangiocarcinoma.","volume":"6","author":"Vijgen","year":"2017","journal-title":"Hepatobiliary Surg Nutr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3350\/cmh.2018.0067","article-title":"Pathologic differential diagnosis of metastatic carcinoma in the liver.","volume":"25","author":"Park","year":"2019","journal-title":"Clin Mol Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/his.13127","article-title":"Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss.","volume":"70","author":"Misumi","year":"2017","journal-title":"Histopathology."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32397","article-title":"Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma.","author":"Jeon","year":"2022","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/hep.31862","article-title":"Molecular characterization of biliary tract cancer predicts chemotherapy and PD-1\/PD-L1 blockade responses.","volume":"74","author":"Yoon","year":"2021","journal-title":"Hepatology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2016.12.025","article-title":"Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens.","volume":"63","author":"Choi","year":"2017","journal-title":"Hum Pathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00000478-200303000-00003","article-title":"CDX2, a Highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas.","volume":"27","author":"Werling","year":"2003","journal-title":"Am J Surg Pathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/jcp.2003.007138","article-title":"Thyroid transcription factor 1 in pulmonary adenocarcinoma.","volume":"57","author":"Stenhouse","year":"2004","journal-title":"J Clin Pathol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/pas.0000000000000138","article-title":"TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.","volume":"38","author":"Surrey","year":"2014","journal-title":"Am J Surg Pathol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/cancers10040108","article-title":"Immunohistochemistry for diagnosis of metastatic carcinomas of unknown primary site.","volume":"10","author":"Selves","year":"2018","journal-title":"Cancers (Basel)."},{"key":"B41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors.","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1309\/BGWQ-P26T-7TR6-VGT3","article-title":"Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: implications for diagnostic prostatic pathology.","volume":"118","author":"Varma","year":"2002","journal-title":"Am J Clin Pathol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jhep.2009.03.017","article-title":"Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas.","volume":"51","author":"Guedj","year":"2009","journal-title":"J Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/PAS.0000000000000343","article-title":"Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.","volume":"39","author":"Shahid","year":"2015","journal-title":"Am J Surg Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1245\/s10434-014-4247-8","article-title":"The ability to diagnose intrahepatic cholangiocarcinoma definitively using novel branched DNA-enhanced albumin RNA in situ hybridization technology.","volume":"23","author":"Ferrone","year":"2016","journal-title":"Ann Surg Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/pai.0000000000000885","article-title":"Utility and limitations of albumin mRNA in situ hybridization detection in the diagnosis of hepatobiliary lesions and metastatic carcinoma to the liver.","volume":"29","author":"Collins","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology.","volume":"16","author":"Banales","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/1097-0142(195907\/08)12:4<753::aid-cncr2820120420>3.0.co;2-l","article-title":"Cholangiolocellular carcinoma of the liver.","volume":"12","author":"Steiner","year":"1959","journal-title":"Cancer."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/hep.22238","article-title":"Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.","volume":"47","author":"Komuta","year":"2008","journal-title":"Hepatology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2017.01.010","article-title":"Mixed hepatocellular cholangiocarcinoma tumors: cholangiolocellular carcinoma is a distinct molecular entity.","volume":"66","author":"Moeini","year":"2017","journal-title":"J Hepatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/liv.13492","article-title":"Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma.","volume":"38","author":"Rhee","year":"2018","journal-title":"Liver Int."},{"key":"B53","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes.","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.5009\/gnl210174","article-title":"Genetic, clinicopathological, and radiological features of intrahepatic cholangiocarcinoma with ductal plate malformation pattern.","author":"Chung","year":"2021","journal-title":"Gut Liver."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1097\/PAS.0b013e31826e0249","article-title":"Intrahepatic cholangiocarcinoma with predominant \u201cductal plate malformation\u201d pattern: a new subtype.","volume":"36","author":"Nakanuma","year":"2012","journal-title":"Am J Surg Pathol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/pas.0000000000001201","article-title":"Cholangiolocellular carcinoma with \u201cductal plate malformation\u201d pattern may be characterized by ARID1A genetic alterations.","volume":"43","author":"Sasaki","year":"2019","journal-title":"Am J Surg Pathol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"621594","DOI":"10.3389\/fonc.2021.621594","article-title":"Treatment and survival patterns of primary adenosquamous carcinoma of the liver: a retrospective analysis.","volume":"11","author":"Gou","year":"2021","journal-title":"Front Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4254\/wjh.v2.i12.419","article-title":"Pathological classification of intrahepatic cholangiocarcinoma based on a new concept.","volume":"2","author":"Nakanuma","year":"2010","journal-title":"World J Hepatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.humpath.2018.04.010","article-title":"Mucinous intrahepatic cholangiocarcinoma: a distinct variant.","volume":"78","author":"Chi","year":"2018","journal-title":"Hum Pathol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ags3.12016","article-title":"Mucinous cholangiocarcinoma: clinicopathological features of the rarest type of cholangiocarcinoma.","volume":"1","author":"Sumiyoshi","year":"2017","journal-title":"Ann Gastroenterol Surg."},{"key":"B61","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/PAS.0b013e31802c0c8a","article-title":"Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.","volume":"31","author":"Haas","year":"2007","journal-title":"Am J Surg Pathol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s40792-020-01041-2","article-title":"Intrahepatic cholangiocarcinoma with clear cell type following laparoscopic curative surgery.","volume":"6","author":"Yamamoto","year":"2020","journal-title":"Surg Case Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1746-1596-9-24","article-title":"Unusual mucoepidermoid carcinoma of the liver misdiagnosed as squamous cell carcinoma by intraoperative histological examination.","volume":"9","author":"Guo","year":"2014","journal-title":"Diagn Pathol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1872-034X.2008.00335.x","article-title":"Mucoepidermoid carcinoma of the liver: report of a rare case and review of the literature.","volume":"38","author":"Arakawa","year":"2008","journal-title":"Hepatol Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1097\/PAS.0000000000001716","article-title":"Lymphoepithelioma-like intrahepatic cholangiocarcinoma is a distinct entity with frequent pTERT\/TP53 mutations and comprises 2 subgroups based on epstein-barr virus infection.","volume":"45","author":"Tsai","year":"2021","journal-title":"Am J Surg Pathol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/his.14580","article-title":"Lymphoepithelioma-like neoplasm of the biliary tract with \u2018probable low malignant potential\u2019.","volume":"80","author":"Khandakar","year":"2022","journal-title":"Histopathology."},{"key":"B67","doi-asserted-by":"publisher","first-page":"701476","DOI":"10.1155\/2010\/701476","article-title":"Intrahepatic sarcomatoid cholangiocarcinoma.","volume":"2010","author":"Malhotra","year":"2010","journal-title":"J Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.anndiagpath.2018.10.005","article-title":"Update on the pathology of liver neoplasms.","volume":"38","author":"Matsukuma","year":"2019","journal-title":"Ann Diagn Pathol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2632010X20925045","DOI":"10.1177\/2632010x20925045","article-title":"Precursor lesions of cholangiocarcinoma: a clinicopathologic review.","volume":"13","author":"Geramizadeh","year":"2020","journal-title":"Clin Pathol."},{"key":"B70","year":"2019","journal-title":"Digestive System Tumours."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.humpath.2007.11.018","article-title":"Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.","volume":"39","author":"Nakanishi","year":"2008","journal-title":"Hum Pathol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.4254\/wjh.v7.i25.2563","article-title":"Clinical and biological significance of precursor lesions of intrahepatic cholangiocarcinoma.","volume":"7","author":"Ettel","year":"2015","journal-title":"World J Hepatol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/cncr.27955","article-title":"KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas.","volume":"119","author":"Hsu","year":"2013","journal-title":"Cancer."},{"key":"B74","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/PAS.0b013e31820ffdf1","article-title":"Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.","volume":"35","author":"Aishima","year":"2011","journal-title":"Am J Surg Pathol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.humpath.2015.12.022","article-title":"Characterization of intraductal papillary neoplasm of bile duct with respect to histopathologic similarities to pancreatic intraductal papillary mucinous neoplasm.","volume":"51","author":"Nakanuma","year":"2016","journal-title":"Hum Pathol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/hep.25786","article-title":"Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?","volume":"56","author":"Rocha","year":"2012","journal-title":"Hepatology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/ajg.2011.316","article-title":"Clinicopathologic features of intraductal papillary neoplasm of the bile duct according to histologic subtype.","volume":"107","author":"Kim","year":"2012","journal-title":"Am J Gastroenterol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/modpathol.2013.112","article-title":"Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.","volume":"27","author":"Schlitter","year":"2014","journal-title":"Mod Pathol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.3390\/jcm9123991","article-title":"Intraductal papillary neoplasm of bile duct: updated clinicopathological characteristics and molecular and genetic alterations.","volume":"9","author":"Nakanuma","year":"2020","journal-title":"J Clin Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.humpath.2021.01.002","article-title":"Reappraisal of pathological features of intraductal papillary neoplasm of bile duct with respect to the type 1 and 2 subclassifications.","volume":"111","author":"Nakanuma","year":"2021","journal-title":"Hum Pathol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/s41379-019-0306-9","article-title":"Targeted next-generation sequencing identifies distinct clinicopathologic and molecular entities of intraductal papillary neoplasms of the bile duct.","volume":"32","author":"Yang","year":"2019","journal-title":"Mod Pathol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/path.5398","article-title":"Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes.","volume":"251","author":"Aoki","year":"2020","journal-title":"J Pathol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/modpathol.2015.61","article-title":"Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases.","volume":"28","author":"Schlitter","year":"2015","journal-title":"Mod Pathol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/gutjnl-2020-322983","article-title":"Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.","volume":"71","author":"Goeppert","year":"2022","journal-title":"Gut."},{"key":"B85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hep.31410","article-title":"The tumor microenvironment in cholangiocarcinoma progression.","volume":"73","author":"Fabris","year":"2021","journal-title":"Hepatology."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1634\/theoncologist.2017-0439","article-title":"Prognostic nomogram based on histological characteristics of fibrotic tumor stroma in patients who underwent curative resection for intrahepatic cholangiocarcinoma.","volume":"23","author":"Jing","year":"2018","journal-title":"Oncologist."},{"key":"B87","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/00000478-199908000-00006","article-title":"The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of \u2018scirrhous-type\u2019 and \u2018nonscirrhous-type\u2019.","volume":"23","author":"Kajiyama","year":"1999","journal-title":"Growth."},{"key":"B88","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.humpath.2017.04.014","article-title":"Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma.","volume":"65","author":"Zhang","year":"2017","journal-title":"Hum Pathol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.21873\/anticanres.14476","article-title":"Prognostic impact of desmoplastic reaction evaluation for intrahepatic cholangiocarcinoma.","volume":"40","author":"Kojima","year":"2020","journal-title":"Anticancer Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.trecan.2019.09.009","article-title":"Fibroblasts fuel immune escape in the tumor microenvironment.","volume":"5","author":"De Jaeghere","year":"2019","journal-title":"Trends Cancer."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1245\/s10434-010-1391-7","article-title":"Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.","volume":"18","author":"Okabe","year":"2011","journal-title":"Ann Surg Oncol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/hep.26585","article-title":"Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.","volume":"58","author":"Clap\u00e9ron","year":"2013","journal-title":"Hepatology."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/hep.24588","article-title":"Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells.","volume":"54","author":"Fingas","year":"2011","journal-title":"Hepatology."},{"key":"B94","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3892\/or_00000309","article-title":"Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma.","volume":"21","author":"Chuaysri","year":"2009","journal-title":"Oncol Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fimmu.2020.00322","article-title":"Hepatic macrophages in liver injury.","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/j.ajpath.2016.06.003","article-title":"Pathogenesis of Kupffer cells in cholestatic liver injury.","volume":"186","author":"Sato","year":"2016","journal-title":"Am J Pathol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12935-020-01687-w","article-title":"Intrahepatic cholangiocarcinoma induced M2-polarized tumor-associated macrophages facilitate tumor growth and invasiveness.","volume":"20","author":"Yuan","year":"2020","journal-title":"Cancer Cell Int."},{"key":"B98","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.trecan.2018.01.007","article-title":"Desmoplastic tumor microenvironment and immunotherapy in cholangiocarcinoma.","volume":"4","author":"H\u00f8gdall","year":"2018","journal-title":"Trends Cancer."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1111\/j.1349-7006.2010.01614.x","article-title":"Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.","volume":"101","author":"Hasita","year":"2010","journal-title":"Cancer Sci."},{"key":"B100","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.3748\/wjg.15.5053","article-title":"Liver tumor infiltrating lymphocytes: comparison of hepatocellular and cholangiolar carcinoma.","volume":"15","author":"Kasper","year":"2009","journal-title":"World J Gastroenterol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1038\/bjc.2013.610","article-title":"Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer.","volume":"109","author":"Goeppert","year":"2013","journal-title":"Br J Cancer."},{"key":"B102","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/s41379-020-00702-9","article-title":"Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes.","volume":"34","author":"Yugawa","year":"2021","journal-title":"Mod Pathol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4143\/crt.2020.704","article-title":"Spatial distribution and prognostic implications of tumor-infiltrating FoxP3- CD4+ T cells in biliary tract cancer.","volume":"53","author":"Kim","year":"2021","journal-title":"Cancer Res Treat."},{"key":"B104","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejca.2017.09.005","article-title":"Characterisation of the immune-related transcriptome in resected biliary tract cancers.","volume":"86","author":"Ghidini","year":"2017","journal-title":"Eur J Cancer."},{"key":"B105","doi-asserted-by":"publisher","first-page":"24644","DOI":"10.18632\/oncotarget.15602","article-title":"PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma.","volume":"8","author":"Fontugne","year":"2017","journal-title":"Oncotarget."},{"key":"B106","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/ott.S288982","article-title":"Clinicopathological and prognostic significance of immunoscore and PD-L1 in intrahepatic cholangiocarcinoma.","volume":"14","author":"Wu","year":"2021","journal-title":"OncoTargets Ther."},{"key":"B107","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1158\/1078-0432.CCR-15-0715","article-title":"PD-L1 and HLA class I antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma.","volume":"22","author":"Sabbatino","year":"2016","journal-title":"J Clin Cancer Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/cancers13030558","article-title":"PD-L1, TMB, MSI, and other predictors of response to immune checkpoint inhibitors in biliary tract cancer.","volume":"13","author":"Rizzo","year":"2021","journal-title":"Cancers (Basel)."},{"key":"B109","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","article-title":"Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.","volume":"68","author":"Wardell","year":"2018","journal-title":"J Hepatol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.18632\/oncotarget.27224","article-title":"Germline mutations in cancer-predisposition genes in patients with biliary tract cancer.","volume":"10","author":"Terashima","year":"2019","journal-title":"Oncotarget."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cncr.32740","article-title":"Germline alterations in patients with biliary tract cancers: a spectrum of significant and previously underappreciated findings.","volume":"126","author":"Maynard","year":"2020","journal-title":"Cancer."},{"key":"B112","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1634\/theoncologist.2016-0415","article-title":"Overall survival and clinical characteristics of BRCA-associated cholangiocarcinoma: a multicenter retrospective study.","volume":"22","author":"Golan","year":"2017","journal-title":"Oncologist."},{"key":"B113","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cancergen.2020.10.001","article-title":"Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos.","volume":"24","author":"Brandi","year":"2020","journal-title":"Cancer Genet."},{"key":"B114","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/mc.2940080415","article-title":"Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.","volume":"8","author":"Kiba","year":"1993","journal-title":"Mol Carcinog."},{"key":"B115","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1634\/theoncologist.2013-0352","article-title":"New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.","volume":"19","author":"Ross","year":"2014","journal-title":"Oncologist."},{"key":"B116","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2017.05.009","article-title":"Common molecular subtypes among asian hepatocellular carcinoma and cholangiocarcinoma.","volume":"32","author":"Chaisaingmongkol","year":"2017","journal-title":"Cancer Cell."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.","volume":"5","author":"Simbolo","year":"2014","journal-title":"Oncotarget."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e115383","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.","volume":"9","author":"Churi","year":"2014","journal-title":"PLoS One."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.","volume":"45","author":"Jiao","year":"2013","journal-title":"Nat Genet."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer.","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet."},{"key":"B121","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1038\/ncomms7120","article-title":"Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity.","volume":"6","author":"Fujimoto","year":"2015","journal-title":"Nat Commun."},{"key":"B122","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.humpath.2019.05.002","article-title":"Distinct histomorphological features are associated with IDH1 mutation in intrahepatic cholangiocarcinoma.","volume":"91","author":"Wang","year":"2019","journal-title":"Hum Pathol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1158\/1078-0432.CCR-21-0412","article-title":"Intrahepatic cholangiocarcinoma with lymph node metastasis: treatment-related outcomes and the role of tumor genomics in patient selection.","volume":"27","author":"Jolissaint","year":"2021","journal-title":"Clin Cancer Res."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.humpath.2011.12.007","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma.","volume":"43","author":"Kipp","year":"2012","journal-title":"Hum Pathol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1245\/s10434-014-3828-x","article-title":"Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets.","volume":"21","author":"Zhu","year":"2014","journal-title":"Ann Surg Oncol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/hep.31829","article-title":"Genetic determinants of outcome in intrahepatic cholangiocarcinoma.","volume":"74","author":"Boerner","year":"2021","journal-title":"Hepatology."},{"key":"B127","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/hep.29764","article-title":"Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma.","volume":"68","author":"Nepal","year":"2018","journal-title":"Hepatology."},{"key":"B128","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention.","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e1004135","DOI":"10.1371\/journal.pgen.1004135","article-title":"Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.","volume":"10","author":"Borad","year":"2014","journal-title":"PLoS Genet."},{"key":"B130","doi-asserted-by":"publisher","first-page":"102170","DOI":"10.1016\/j.ctrv.2021.102170","article-title":"Targeting FGFR inhibition in cholangiocarcinoma.","volume":"95","author":"Goyal","year":"2021","journal-title":"Cancer Treat Rev."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma.","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3390\/ijms19051421","article-title":"Microsatellite instability occurs rarely in patients with cholangiocarcinoma: a retrospective study from a German tertiary care hospital.","volume":"19","author":"Winkelmann","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41416-018-0199-2","article-title":"Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma.","volume":"120","author":"Goeppert","year":"2019","journal-title":"Br J Cancer."},{"key":"B134","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12935-019-1091-8","article-title":"Microsatellite instability: a review of what the oncologist should know.","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/0016-5085(95)90650-9","article-title":"Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology.","volume":"109","author":"Ohashi","year":"1995","journal-title":"Gastroenterology."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/hep.30493","article-title":"Integrative analysis defines distinct prognostic subgroups of intrahepatic cholangiocarcinoma.","volume":"69","author":"Goeppert","year":"2019","journal-title":"Hepatology."},{"key":"B137","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12885-020-06804-6","article-title":"Distinct clinical and prognostic implication of IDH1\/2 mutation and other most frequent mutations in large duct and small duct subtypes of intrahepatic cholangiocarcinoma.","volume":"20","author":"Ma","year":"2020","journal-title":"BMC Cancer."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/ng.2806","article-title":"Exome sequencing identifies distinct mutational patterns in liver fluke\u2013related and non-infection-related bile duct cancers.","volume":"45","author":"Chan-on","year":"2013","journal-title":"Nat Genet."},{"key":"B139","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.1038\/ncomms6696","article-title":"Mutational landscape of intrahepatic cholangiocarcinoma.","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","article-title":"Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.","volume":"142","author":"Andersen","year":"2012","journal-title":"Gastroenterology."},{"key":"B141","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology.","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet."},{"key":"B142","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/hep.31092","article-title":"Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma.","volume":"72","author":"Job","year":"2020","journal-title":"Hepatology."},{"key":"B143","doi-asserted-by":"publisher","first-page":"100356","DOI":"10.1016\/j.ctarc.2021.100356","article-title":"IDH inhibitors in advanced cholangiocarcinoma: another arrow in the quiver?","volume":"27","author":"Rizzo","year":"2021","journal-title":"Cancer Treat Res Commun."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/jamaoncol.2021.3836","article-title":"Final overall survival efficacy results of Ivosidenib for patients with advanced cholangiocarcinoma with IDH1 mutation: the phase 3 randomized clinical ClarIDHy trial.","volume":"7","author":"Zhu","year":"2021","journal-title":"JAMA Oncol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.3390\/cancers13205169","article-title":"Intrahepatic cholangiocarcinoma: a summative review of biomarkers and targeted therapies.","volume":"13","author":"Acher","year":"2021","journal-title":"Cancers (Basel)."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/po.19.00223","article-title":"Genomic characterization of ERBB2-driven biliary cancer and a case of response to Ado-Trastuzumab Emtansine.","volume":"3","author":"Mondaca","year":"2019","journal-title":"JCO Precis Oncol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group.","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann Oncol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.857140\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T02:56:27Z","timestamp":1648695387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.857140\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":147,"alternative-id":["10.3389\/fmed.2022.857140"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.857140","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"article-number":"857140"}}